SCHEMBL10240950

SCHEMBL10240950

Cc1ccccc1C(C/C(=N\O)c1ccncc1)c1ccc(C(=O)O)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 7/20 0.74
NAPRT Q6XQN6 1/20 0.41
EPHX2 P34913 1/20 0.37
NR3C2 P08235 1/20 0.36
GAA P10253 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
HPGD P15428 2/20 0.36
CYP2C19 P33261 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 2/20 0.35
PLOD2 O00469 1/20 0.35
PLOD3 O60568 1/20 0.35
CYP2D6 P10635 1/20 0.35
PLOD1 Q02809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL363306 1.00 GPBAR1 (0.74) GPBAR1NAPRTEPHX2NR3C2GAA
SCHEMBL363545 1.00 GPBAR1 (0.74) GPBAR1NAPRTEPHX2NR3C2GAA
SCHEMBL10240982 0.88 GPBAR1 (0.94) GPBAR1NR3C2RXRARXRBRXRG
SCHEMBL364915 0.88 GPBAR1 (0.94) GPBAR1NR3C2RXRARXRBRXRG
SCHEMBL363423 0.88 GPBAR1 (0.94) GPBAR1NR3C2RXRARXRBRXRG
SCHEMBL361887 0.88 GPBAR1 (0.94) GPBAR1NR3C2RXRARXRBRXRG
SCHEMBL1389693 0.88 GPBAR1 (0.94) GPBAR1NR3C2RXRARXRBRXRG
SCHEMBL364113 0.87 GPBAR1 (0.61) GPBAR1NR3C2GAACYP1A2CYP3A4
SCHEMBL364112 0.87 GPBAR1 (0.61) GPBAR1NR3C2GAACYP1A2CYP3A4
SCHEMBL14936850 0.87 GPBAR1 (0.75) GPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885NAPRT 3243/4885EPHX2 1909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.